Literature DB >> 9588848

Fat distribution and changes in the blood brain barrier in a rat model of cerebral arterial fat embolism.

P A Drew1, E Smith, P D Thomas.   

Abstract

This study was designed to determine the distribution of fat which reaches the brain by the internal carotid artery, and the consequent alterations in the blood brain barrier, in a rat model of cerebral arterial fat embolism. The distribution of the blood flow in this model was determined by the injection of radiolabelled microspheres. Over 44% were trapped in the brain, 43% in the extracerebral tissues of the head and neck, and 7% in the lungs. Over 30% of radiolabelled triolein was present within the brain 30 min after injection, and 4% still remained after 17 days. Approximately 25% of the triolein which went to the brain moved through the cerebral vessels and left within the first 15 min. The majority of the triolein distributed to the ipsilateral cerebral hemisphere, with significantly less to the contralateral cerebral hemisphere, brain stem and cerebellum. The blood brain barrier opened, as measured by uptake of 99mTc, within the first 15 min and remained open for at least 3 days. A significant percentage of fat reaching the brain persists for days, and causes rapid and long-lasting damage to the blood brain barrier.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9588848     DOI: 10.1016/s0022-510x(98)00039-2

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

1.  Contrast-enhanced MR imaging of cerebral fat embolism: case report and review of the literature.

Authors:  Andrew D Simon; John L Ulmer; James M Strottmann
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

2.  'Metabolic syndrome' in the brain: deficiency in omega-3 fatty acid exacerbates dysfunctions in insulin receptor signalling and cognition.

Authors:  Rahul Agrawal; Fernando Gomez-Pinilla
Journal:  J Physiol       Date:  2012-04-02       Impact factor: 5.182

3.  Temporal profiles of aquaporin 4 expression and astrocyte response in the process of brain damage in fat embolism model in rats.

Authors:  Toru Gohara; Kazuyoshi Ishida; Kazuhiko Nakakimura; Mitsuyoshi Yoshida; Shiro Fukuda; Mishiya Matsumoto; Takefumi Sakabe
Journal:  J Anesth       Date:  2010-01-29       Impact factor: 2.078

4.  Experimental cerebral fat embolism: embolic effects of triolein and oleic acid depicted by MR imaging and electron microscopy.

Authors:  Hak Jin Kim; Jong Hwa Lee; Chang Hun Lee; Suk Hong Lee; Tae Yong Moon; Byung Mann Cho; Hae Kyu Kim; Byung Rae Park; Kee Hyun Chang
Journal:  AJNR Am J Neuroradiol       Date:  2002-10       Impact factor: 3.825

5.  Impairment of Novel Object Recognition Memory and Brain Insulin Signaling in Fructose- but Not Glucose-Drinking Female Rats.

Authors:  Gemma Sangüesa; Mar Cascales; Christian Griñán; Rosa María Sánchez; Núria Roglans; Mercè Pallàs; Juan Carlos Laguna; Marta Alegret
Journal:  Mol Neurobiol       Date:  2018-01-26       Impact factor: 5.590

6.  A high fructose diet impairs spatial memory in male rats.

Authors:  A P Ross; T J Bartness; J G Mielke; M B Parent
Journal:  Neurobiol Learn Mem       Date:  2009-06-12       Impact factor: 2.877

7.  MR imaging of the brain in fat embolism syndrome.

Authors:  Joseph Jen-Sho Chen; James C Ha; Stuart E Mirvis
Journal:  Emerg Radiol       Date:  2007-10-13

8.  [Post-traumatic fat embolism syndrome].

Authors:  Adnane Mohamed Berdai; Abdelkarim Shimi; Mohammed Khatouf
Journal:  Pan Afr Med J       Date:  2014-02-02

Review 9.  The emerging role of dietary fructose in obesity and cognitive decline.

Authors:  Shaheen E Lakhan; Annette Kirchgessner
Journal:  Nutr J       Date:  2013-08-08       Impact factor: 3.271

10.  The Protective Roles of Urinary Trypsin Inhibitor in Brain Injury Following Fat Embolism Syndrome in a Rat Model.

Authors:  Lili Xiong; Linlin Sun; Shanshan Liu; Xingyun Zhu; Ze Teng; Junhao Yan
Journal:  Cell Transplant       Date:  2018-11-19       Impact factor: 4.064

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.